ELVN
Price
$24.59
Change
-$0.33 (-1.32%)
Updated
Nov 15, 03:08 PM (EDT)
118 days until earnings call
VYNE
Price
$2.84
Change
-$0.07 (-2.41%)
Updated
Nov 14 closing price
Ad is loading...

ELVN vs VYNE

Header iconELVN vs VYNE Comparison
Open Charts ELVN vs VYNEBanner chart's image
Enliven Therapeutics
Price$24.59
Change-$0.33 (-1.32%)
Volume$400
CapitalizationN/A
VYNE Therapeutics
Price$2.84
Change-$0.07 (-2.41%)
Volume$25.67K
CapitalizationN/A
ELVN vs VYNE Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ELVN vs. VYNE commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Sell and VYNE is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ELVN: $24.92 vs. VYNE: $2.84)
Brand notoriety: ELVN and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 71% vs. VYNE: 30%
Market capitalization -- ELVN: $1.18B vs. VYNE: $41.89M
ELVN [@Biotechnology] is valued at $1.18B. VYNE’s [@Biotechnology] market capitalization is $41.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileVYNE’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • VYNE’s FA Score: 1 green, 4 red.
According to our system of comparison, VYNE is a better buy in the long-term than ELVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 5 TA indicator(s) are bullish while VYNE’s TA Score has 3 bullish TA indicator(s).

  • ELVN’s TA Score: 5 bullish, 4 bearish.
  • VYNE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than VYNE.

Price Growth

ELVN (@Biotechnology) experienced а -14.07% price change this week, while VYNE (@Biotechnology) price change was -9.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

ELVN is expected to report earnings on Mar 13, 2025.

VYNE is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.18B) has a higher market cap than VYNE($41.9M). ELVN YTD gains are higher at: 80.058 vs. VYNE (21.888).
ELVNVYNEELVN / VYNE
Capitalization1.18B41.9M2,809%
EBITDAN/AN/A-
Gain YTD80.05821.888366%
P/E RatioN/A0.86-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A180K-
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVNVYNE
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 10 days ago
0%
Bullish Trend 8 days ago
0%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-3.41%
CRNX - ELVN
43%
Loosely correlated
+1.26%
VYGR - ELVN
41%
Loosely correlated
-7.03%
LABFF - ELVN
39%
Loosely correlated
N/A
ACLX - ELVN
38%
Loosely correlated
-5.05%
SER - ELVN
37%
Loosely correlated
N/A
More

VYNE and

Correlation & Price change

A.I.dvisor tells us that VYNE and GLTO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VYNE and GLTO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
-2.41%
GLTO - VYNE
30%
Poorly correlated
+0.44%
AURA - VYNE
30%
Poorly correlated
-3.48%
OBIO - VYNE
28%
Poorly correlated
+2.31%
ELVN - VYNE
27%
Poorly correlated
-3.41%
SANA - VYNE
27%
Poorly correlated
-2.63%
More